BMY · Bristol Myers Squibb Co · Executive Compensation

$62.40 -0.46 (-0.73%) At close · Sep 30

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$128.41B

2.04B

Volume · Sep 30 15.87M Avg daily vol (3M) 11.02M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Boerner	Board Chair and Chief Executive Officer	$1,586,346	$0	$16,061,399	—	$3,754,684	$477,490	$21,879,919
Samit Hirawat	Former EVP, Chief Medical Officer, Head of Development	$964,904	$0	$5,815,320	—	$928,658	$2,625,351	$10,334,233
Cristian Massacesi	M.D. EVP, Chief Medical Officer, Head of Development	$388,462	$1,125,000	$7,853,994	—	$660,876	$44,618	$10,072,950
Adam Lenkowsky	EVP, Chief Commercialization Officer	$1,131,731	$0	$6,136,800	—	$1,794,732	$250,029	$9,340,352
David Elkins	EVP and Chief Financial Officer	$1,140,442	$0	$5,981,513	—	$1,799,484	$256,151	$9,177,590
Greg Meyers	EVP, Chief Digital and Technology Officer	$1,072,692	$0	$4,209,168	—	$1,669,036	$230,277	$7,181,173

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Boerner	Board Chair and Chief Executive Officer	$1,536,538	$0	$13,643,063	—	$3,235,581	$372,436	$18,787,618
David Elkins	EVP and Chief Financial Officer	$1,115,000	$0	$5,778,244	—	$1,564,234	$250,093	$8,707,571
Samit Hirawat	EVP, Chief Medical Officer, Head of Development	$1,115,000	$0	$5,617,762	—	$1,564,234	$289,018	$8,586,014
Sandra Leung	EVP and General Counsel	$1,150,000	$0	$3,959,204	—	$1,613,335	$289,251	$7,011,790
Karin Shanahan	EVP, Global Product Development & Supply	$1,009,615	$0	$4,145,908	—	$1,278,651	$132,407	$6,566,581

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Boerner	Board Chair and Chief Executive Officer	$1,256,921	$0	$5,326,178	—	$1,567,098	$311,636	$8,461,833
David Elkins	EVP and Chief Financial Officer	$1,106,176	$0	$4,882,143	—	$866,318	$311,663	$7,166,300
Samit Hirawat	EVP, Chief Medical Officer, Head of Development	$1,103,781	$0	$3,616,394	—	$1,234,117	$279,335	$6,233,627
Sandra Leung	EVP and General Counsel	$1,147,819	$0	$3,345,168	—	$1,123,091	$307,403	$5,923,481

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Elkins	EVP and Chief Financial Officer	$1,073,859	$0	$4,922,614	—	$1,397,863	$252,954	$7,647,290
Christopher Boerner	Board Chair and Chief Executive Officer	$1,064,049	$0	$4,256,197	—	$1,274,626	$285,348	$6,880,220
Sandra Leung	EVP and General Counsel	$1,133,074	$0	$3,441,053	—	$1,238,952	$291,748	$6,104,827

Executive changes

Person	Role	Change	Effective	Filed
Cristian Massacesi	Executive Vice President, Chief Medical Officer, and Head of Development	Appointed	2025-08-01	2025-07-25
Sandra Leung	Executive Vice President, General Counsel	Retired	—	2025-02-18
Michael R. McMullen	member of the Board	Appointed	2024-07-01	2024-06-18
Phil Holzer	Senior Vice President and Controller	Appointed	2024-02-15	2024-02-15
Christopher Boerner	member of the Board	Appointed	2023-05-02	2023-05-04
Christopher Boerner	Chief Executive Officer	Appointed	2023-11-01	2023-05-04
Christopher Boerner	Chief Operating Officer	Appointed	2023-04-26	2023-05-04
Christopher Boerner, Ph.D.	Chief Executive Officer	Appointed	2023-11-01	2023-04-26
Christopher Boerner, Ph.D.	Chief Operating Officer	Appointed	2023-04-26	2023-04-26
Giovanni Caforio, M.D.	Chief Executive Officer	Retired	2023-11-01	2023-04-26
Dr. Rupert Vessey	Executive Vice President, Research and Early Development	Resigned	2023-07-03	2023-01-31

Key facts CIK 14272 CUSIP 110122108 13F (30d) 80 filings 31 filers Visit website Investor relations